Wiley Launches AntiBase 2005 and AmicBase 2005
John Wiley & Sons, Inc., announced the launch of AntiBase 2005 and AmicBase 2005, two new comprehensive database products designed for researchers and scientists in organic chemistry, biochemistry, biotechnology, and pharmaceuticals.
AntiBase 2005 is a database of 31,022 natural compounds from microorganisms and higher fungi. The data in AntiBase 2005 have been collected from the primary and secondary literature and then carefully checked and validated. Included in the database: descriptive data (molecular formula and mass, elemental composition, CAS registry number); physico-chemical data (melting point, optical rotation); spectroscopic data (UV, 13C-NMR, IR and mass spectra); biological data (pharmacological activity, toxicity); information on origin and isolation; and a summary of literature sources. For those compounds where no measured spectra are available, the 2005 edition of AntiBase utilizes predicted 13C-NMR spectra produced by SpecInfo, the spectrum prediction program. Calculated high resolution molecular masses are also included in this new update.
AmicBase 2005 contains information about the antimicrobial and toxicological properties of pharmaceutical drugs and natural compounds produced through microorganisms and higher plants. Compound groups included in the database are approved antibiotic drugs available in United States, Japan and Europe and encompass antiseptics, disinfectants and preservatives used in food, cosmetics and in the pharmaceutical industry. The database contains 160,149 data records of 7,474 compounds and includes: descriptive data (molecular formula and mass, CAS number, EINECS, 2D and 3D structures); inhibitory data (MIC and others) including a brief description of test method and references; and toxicology data (LD50), which also include short references.
Topics
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.